A Study of ELAPRASE in Treatment-na ïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
Conditions: Mucopolysaccharidosis (MPS); Hunter Syndrome Interventions: Drug: ELAPRASE; Drug: Rituximab; Drug: Methotrexate; Drug: Intravenous Immunoglobulin (IVIG) Sponsors: Takeda; Takeda Development Center Americas, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials